ES2140620T3 - Derivados de oxopiridinylquinoxalina. - Google Patents

Derivados de oxopiridinylquinoxalina.

Info

Publication number
ES2140620T3
ES2140620T3 ES95302326T ES95302326T ES2140620T3 ES 2140620 T3 ES2140620 T3 ES 2140620T3 ES 95302326 T ES95302326 T ES 95302326T ES 95302326 T ES95302326 T ES 95302326T ES 2140620 T3 ES2140620 T3 ES 2140620T3
Authority
ES
Spain
Prior art keywords
lower alkyl
substituted
nitro
halogen
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95302326T
Other languages
English (en)
Inventor
Susumu Takada
Nobuo Chomei
Makoto Adachi
Masami Eigyo
Kazuo Kawasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2140620T3 publication Critical patent/ES2140620T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE PRESENTA UN DERIVADO DE LA OXOPIRIDINILQUINOLAXINA REPRESENTADO POR LA SIGUIENTE FORMULA (I) ASI COMO LAS SALES FARMACOLOGICAMENTE ACEPTABLES DEL MISMO; EN DONDE R1 ES HIDROGENO, HALOGENO, NITRO O TRIHALOMETIL; R2 ES HIDROGENO, HALOGENO, NITRO, CIANO, TRIHALOMETIL, CARBAMOIL, CARBAMOIL SUSTITUIDO CON ALQUIL INFERIOR, SULFAMOIL, O SULFAMOIL SUSTITUIDO CON ALQUIL INFERIOR; R3 ES HIDROGENO, NITRO O HALOGENO; R4 ES HALOGENO; ALQUIL INFERIOR, ALQUIL INFERIOR SUSTITUIDO, CICLOALQUIL INFERIOR, O CICLOALQUIL INFERIOR SUSTITUIDO; R5''S SON SUSTITUYENTE SELECCIONADOS INDEPENDIENTEMENTE ENTRE EL GRUPO QUE CONSTA DE HALOGENO, NITRO, CIANO, ALQUIL INFERIOR, CARBAMOIL Y CARBAMOIL SUSTITUIDO CON ALQUIL INFERIOR; Y N ES UN ENTERO ENTRE 0 Y 4. EL DERIVADO TRABAJA COMO AGENTE ANTAGONISTA CONTRA TANTO LOS RECEPTORES DEL NMDA COMO CONTRA LOS RECEPTORES DEL AMPA, DE MANERA QUE ES EFECTIVO COMO AGENTE TERAPEUTICO PARA ENFERMEDADES NEUROLOGICAS PROVOCADAS POR LA UNION DE AMINOACIDOS EXCITATORIOS A LOS RECEPTORES.
ES95302326T 1994-04-08 1995-04-07 Derivados de oxopiridinylquinoxalina. Expired - Lifetime ES2140620T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7090994 1994-04-08

Publications (1)

Publication Number Publication Date
ES2140620T3 true ES2140620T3 (es) 2000-03-01

Family

ID=13445121

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95302326T Expired - Lifetime ES2140620T3 (es) 1994-04-08 1995-04-07 Derivados de oxopiridinylquinoxalina.

Country Status (14)

Country Link
US (1) US5677305A (es)
EP (1) EP0676397B1 (es)
KR (1) KR100363003B1 (es)
CN (1) CN1044241C (es)
AT (1) ATE185806T1 (es)
AU (1) AU688459B2 (es)
CA (1) CA2146478A1 (es)
DE (1) DE69512816T2 (es)
DK (1) DK0676397T3 (es)
ES (1) ES2140620T3 (es)
GR (1) GR3032406T3 (es)
HU (1) HUT72064A (es)
TW (1) TW300894B (es)
ZA (1) ZA952841B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative
AUPN842196A0 (en) * 1996-03-05 1996-03-28 Fujisawa Pharmaceutical Co., Ltd. New compound
EP1020453B1 (en) * 1997-09-01 2004-05-19 Kyorin Pharmaceutical Co., Ltd. 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both
BR9910859A (pt) 1998-06-01 2001-03-13 Shionogi & Co Derivados de cianoiminoquinoxalina
US8039637B2 (en) * 2005-06-23 2011-10-18 Array Biopharma Inc. Process for preparing benzimidazole compounds
WO2010053757A1 (en) 2008-10-29 2010-05-14 Gilead Palo Alto, Inc. 2 -oxoquinoxalin blockers of the late sodium channel
WO2010074807A1 (en) 2008-10-30 2010-07-01 Gilead Palo Alto, Inc. 3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
CN103664806B (zh) * 2013-12-16 2016-06-29 山东汇海医药化工有限公司 一种n-乙酰乙酰基-6-甲氧基-7-氨基喹喔啉-2，3-二酮的制备方法
EP3589616A1 (en) 2017-02-28 2020-01-08 Universitat Autònoma de Barcelona (nitro-phenyl)-nitropyridine compounds for treating synucleinopathies
WO2019161917A1 (en) 2018-02-23 2019-08-29 Universitat Autonoma De Barcelona 4-substituted 1-ethenylsulfonyl-2-nitrobenzene compounds for treating synucleinopathies
WO2024083850A1 (en) 2022-10-18 2024-04-25 ETH Zürich Electrocatalyst

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE66149B1 (en) * 1986-09-16 1995-12-13 Novo Nordisk As Quinoxaline compounds and their preparation and use
JP2635662B2 (ja) * 1987-03-23 1997-07-30 ノボ・ノルデイスク・アクツイエルスカブ ヘテロ環状化合物，その製造方法及びその使用法
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK160941C (da) * 1988-06-28 1991-10-21 Novo Nordisk As Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
US5153195A (en) * 1988-12-22 1992-10-06 Novo Nordisk A/S Quinoxaline compounds and their preparation and use
ATE194985T1 (de) * 1990-11-06 2000-08-15 Yamanouchi Pharma Co Ltd Kondensiertes pyrazinderivat
JPH04193876A (ja) * 1990-11-26 1992-07-13 Sumitomo Chem Co Ltd キノキザリン誘導体、その製造法およびそれを有効成分とする除草剤
DK73091D0 (da) * 1991-04-22 1991-04-22 Novo Nordisk As Quinoxalinforbindelser, deres fremstilling og anvendelse
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
JPH06228112A (ja) * 1993-02-05 1994-08-16 Yamanouchi Pharmaceut Co Ltd （１ｈ，４ｈ）キノキサリン誘導体
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative

Also Published As

Publication number Publication date
ZA952841B (en) 1995-12-18
CN1044241C (zh) 1999-07-21
GR3032406T3 (en) 2000-05-31
TW300894B (es) 1997-03-21
HUT72064A (en) 1996-03-28
EP0676397B1 (en) 1999-10-20
KR950032171A (ko) 1995-12-20
DE69512816T2 (de) 2000-04-27
KR100363003B1 (ko) 2003-02-11
ATE185806T1 (de) 1999-11-15
AU1625695A (en) 1995-10-19
EP0676397A1 (en) 1995-10-11
DE69512816D1 (de) 1999-11-25
CA2146478A1 (en) 1995-10-09
AU688459B2 (en) 1998-03-12
US5677305A (en) 1997-10-14
CN1123792A (zh) 1996-06-05
DK0676397T3 (da) 2000-04-03
HU9501026D0 (en) 1995-06-28

Similar Documents

Publication Publication Date Title
NO913750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
ATE180468T1 (de) Anthranilsäure derivate
ATE225770T1 (de) Difluoroprostaglandin-derivate und ihre anwendung
AU692090B2 (en) Novel 4,6-diarylpyrimidine derivatives and salts thereof
ATE139233T1 (de) Annelierte thiophen-derivate, ihre herstellung und verwendung
ES2173074T3 (es) Derivados de xantina, procedimiento para su preparacion y su uso farmaceutico.
DE69418243D1 (de) N-Heteroaryl-N'-Phenylharnstoffderivate, ihre Herstellung und Verwendung
CA2160444A1 (en) Aroyl-piperdine derivatives
NO813359L (no) Fremgangsmaate for fremstilling av 1,2,3,4-tetrahydro-isokinolin-3-karboksylsyre-derivater
ES2140620T3 (es) Derivados de oxopiridinylquinoxalina.
CA2093403A1 (en) Therapeutic agent for parkinson's disease
NZ238956A (en) 3-arylindole or 3-arylindazole derivatives and medicaments thereof.
EP1004573A4 (en) ARYLOXYANILINE DERIVATIVES
CA2119662A1 (fr) Nouveaux derives bicycliques azotes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE325610T1 (de) Xanthinderivative zur behandlung von hirnischämie
EP1034783A4 (en) AMIDE DERIVATIVES
WO2002094770A3 (en) Aminoalcohol derivatives
ATE219486T1 (de) Trizyklische indol-2-carbonsäure derivate als selektive nmda rezeptor antagonisten
NO910904D0 (no) Fremgangsmaate for fremstilling av en substituert aminforbindelse.
HU9602534D0 (en) Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity
ES2141134T3 (es) Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.
ATE103490T1 (de) Derivate der p-guanidinobenzoesaeure zur behandlung der zerebrovaskulaeren kontraktion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 676397

Country of ref document: ES